3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
50
Carcinoma, Non-Small-Cell Lung
26
Squamous Cell Carcinoma of Head and Neck
25
Head and Neck Neoplasms
12
Neoplasm Metastasis
11
Neoplasms
10
Colonic Neoplasms
10
Rectal Neoplasms
9
Pancreatic Neoplasms
9
Lung Neoplasms
9
Mouth Neoplasms
6
Carcinoma, Squamous Cell
6
Carcinoma
6
Laryngeal Neoplasms
5
Hypopharyngeal Neoplasms
5
Oropharyngeal Neoplasms
4
Thyroid Neoplasms
3
Solid Tumors
3
Ovarian Neoplasms
3
Gastrointestinal Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Pancreatic Ductal
3
Breast Neoplasms
3
Sarcoma
2
Recurrence
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Laryngeal Diseases
2
mCRC
1
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Interventions
Etoposide
30
Carboplatin
29
atezolizumab
17
durvalumab
16
Cisplatin
14
Topotecan
11
Specimen Handling
9
PM 01183
9
Magnetic Resonance Spectroscopy
7
pembrolizumab
6
olaparib
5
berzosertib
4
anlotinib
4
Radiotherapy
4
Nivolumab
4
Irinotecan
4
Drug Therapy
4
tremelimumab
3
toripalimab
3
tislelizumab
3
Paclitaxel
3
Injections
3
Docetaxel
3
Biopsy
3
Bevacizumab
3
AMG 757
3
sacituzumab govitecan
2
monalizumab
2
cabozantinib
2
Temozolomide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
Cetuximab
×
90 days
×
Clear all
No trials found.